Dimitrios Bafaloukos

Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon

Helen Gogas, J. Ioannovich, Urania Dafni et al. · New England Journal of Medicine · 2006 · 562 citations

Life Sciences, Immunology, Oncology +16

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group

Aristotelis Bamias, Gerasimos Aravantinos, C. Deliveliotis et al. · Journal of Clinical Oncology · 2003 · 188 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

Evangelia Razis, Mattheos Bobos, Vassiliki Kotoula et al. · Breast Cancer Research and Treatment · 2011 · 177 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

C. Christodoulou, Dimitrios Bafaloukos, P. Kosmidis et al. · Annals of Oncology · 2001 · 176 citations

Medicine, Oncology, Pharmacology +16

Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung Cancer: An Analytical Database

Samuel Murray, Issa J Dahabreh, Helena Linardou et al. · Journal of Thoracic Oncology · 2008 · 154 citations · Full text

Medicine, Oncology, Pharmacology +17